Effects of alcohol consumption on eight circulating markers of liver fibrosis

被引:28
作者
Ponomarenko, Y
Leo, MA
Kroll, W
Lieber, CS [1 ]
机构
[1] Vet Affairs Med Ctr, Liver Dis & Nutr Sect, Bronx, NY 10468 USA
[2] Mt Sinai Sch Med, Bronx, NY 10468 USA
[3] Bayer AG, D-5600 Wuppertal, Germany
来源
ALCOHOL AND ALCOHOLISM | 2002年 / 37卷 / 03期
关键词
D O I
10.1093/alcalc/37.3.252
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
A number of circulating breakdown products of collagen or other components of extracellular matrix, matrix degrading metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) have been proposed as markers of hepatic fibrosis. However, the published results lack consistency. Since many of the patients with fibrosis studied were alcoholics, the question was raised whether recent alcohol consumption may affect the results obtained. Using sandwich-type assays of radioimmunoassay technology with corresponding antibodies, we studied eight markers of liver fibrosis: laminin, tenascin, undulin, TIMP-1, collagen VI, procollagen type III (PIIINP), hyaluronic acid (HA) and MMP-2. A group of 10 alcoholics was studied after significant alcohol consumption and following 2 weeks of abstinence, verified with repeated breath alcohol measurement. Laminin was significantly reduced at 1 week (22%) and at 2 weeks (30%). Similarly, tenascin and undulin were also significantly decreased. By contrast, TIMP-1, collagen VI, PIIINP, HA and MMP-2 did not significantly change. The mode of action of alcohol on these tests is unknown. These differences must be considered when using those measurements to assess liver fibrosis.
引用
收藏
页码:252 / 255
页数:4
相关论文
共 10 条
[1]  
LI JJ, 1994, HEPATOLOGY, V19, P1418, DOI 10.1002/hep.1840190616
[2]  
LIEBER CS, 1992, MED NUTR COMPLICATIO, P185
[3]   GENETIC-ASPECTS AND RISK-FACTORS IN ALCOHOLISM AND ALCOHOLIC LIVER-DISEASE [J].
LUMENG, L ;
CRABB, DW .
GASTROENTEROLOGY, 1994, 107 (02) :572-578
[4]   SERUM PROCOLLAGEN TYPE-III N-TERMINAL PEPTIDES AND LAMININ P1-PEPTIDE IN ALCOHOLIC LIVER-DISEASE [J].
NOUCHI, T ;
WORNER, TM ;
SATO, S ;
LIEBER, CS .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1987, 11 (03) :287-291
[5]   Noninvasive diagnosis of hepatic fibrosis or cirrhosis [J].
Oberti, F ;
Valsesia, E ;
Pilette, C ;
Rousselet, MC ;
Bedossa, P ;
Aube, C ;
Gallois, Y ;
Rifflet, H ;
Maiga, MY ;
PenneauFontbonne, D ;
Cales, P .
GASTROENTEROLOGY, 1997, 113 (05) :1609-1616
[6]   LIVER FIBROSIS IN ALCOHOLICS [J].
SATO, S ;
NOUCHI, T ;
WORNER, TM ;
LIEBER, CS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (11) :1471-1473
[7]  
SAVOLAINEN ER, 1984, ALCOHOL CLIN EXP RES, V8, P384
[8]  
Snedecor G. W., 1980, STAT METHODS
[9]  
TANIKAWA K, 1994, PATHOL RES PRACT, V190, P960
[10]   PERIVENULAR FIBROSIS AS PRECURSOR LESION OF CIRRHOSIS [J].
WORNER, TM ;
LIEBER, CS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (05) :627-630